Cleared Abbreviated

K161971 - Bindex BI-2 (FDA 510(k) Clearance)

Jan 2017
Decision
175d
Days
Class 2
Risk

K161971 is an FDA 510(k) clearance for the Bindex BI-2. This device is classified as a Bone Sonometer (Class II - Special Controls, product code MUA).

Submitted by Bone Index Finland , Ltd. (Kuopio, FI). The FDA issued a Cleared decision on January 9, 2017, 175 days after receiving the submission on July 18, 2016.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.1180. A Bone Sonometer Is A Device That Transmits Ultrasound Energy Into The Human Body To Measure Acoustic Properties Of Bone That Indicate Overall Bone Health And Fracture Risk. The Primary Components Of The Device Are A Voltage Generator, A Transmitting Transducer, A Receiving Transducer, And Hardware And Software For Reception And Processing Of The Received Ultrasonic Signal. Reclassified From Class 3 Pma To Class 2 510(k) 892.1180 [docket No. Fda-2005-n-0346] Reclassification Of Bone Sonometers.

Submission Details

510(k) Number K161971 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 18, 2016
Decision Date January 09, 2017
Days to Decision 175 days
Submission Type Abbreviated
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code MUA - Bone Sonometer
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.1180
Definition A Bone Sonometer Is A Device That Transmits Ultrasound Energy Into The Human Body To Measure Acoustic Properties Of Bone That Indicate Overall Bone Health And Fracture Risk. The Primary Components Of The Device Are A Voltage Generator, A Transmitting Transducer, A Receiving Transducer, And Hardware And Software For Reception And Processing Of The Received Ultrasonic Signal. Reclassified From Class 3 Pma To Class 2 510(k) 892.1180 [docket No. Fda-2005-n-0346] Reclassification Of Bone Sonometers